6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide

C73H72Cl3F3N18O11 — CID 158720267

IUPAC6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide
SMILESCCn1c(=O)n(C)c2c3cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n(CC(=O)N4CC(C)(F)C4)c3ncc21.CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.Cn1c(=O)[nH]c2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21
InChIInChI=1S/C26H26ClFN6O4.C24H22ClFN6O4.C23H24ClFN6O3/c1-4-33-19-11-29-22-17(21(19)31(3)25(33)38)9-18(23(36)30-10-15-5-7-16(27)8-6-15)24(37)34(22)12-20(35)32-13-26(2,28)14-32;1-24(26)11-31(12-24)18(33)10-32-20-15(19-17(9-27-20)29-23(36)30(19)2)7-16(22(32)35)21(34)28-8-13-3-5-14(25)6-4-13;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13/h5-9,11H,4,10,12-14H2,1-3H3,(H,30,36);3-7,9H,8,10-12H2,1-2H3,(H,28,34)(H,29,36);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33)
InChIKeyIJVFNBCLUQKADM-UHFFFAOYSA-N
MW1540.85 g/mol
LogP6.13
Rot. Bonds17

About 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide

6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide (PubChem CID 158720267) has the molecular formula C73H72Cl3F3N18O11 and a molecular weight of 1540.85 g/mol. Its IUPAC name is 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide.

Molecular Properties

Compound Name6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide
PubChem CID158720267
Molecular FormulaC73H72Cl3F3N18O11
Molecular Weight1540.85 g/mol
Exact Mass1538.46
IUPAC Name6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide
SMILESCCn1c(=O)n(C)c2c3cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n(CC(=O)N4CC(C)(F)C4)c3ncc21.CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.Cn1c(=O)[nH]c2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21
InChIInChI=1S/C26H26ClFN6O4.C24H22ClFN6O4.C23H24ClFN6O3/c1-4-33-19-11-29-22-17(21(19)31(3)25(33)38)9-18(23(36)30-10-15-5-7-16(27)8-6-15)24(37)34(22)12-20(35)32-13-26(2,28)14-32;1-24(26)11-31(12-24)18(33)10-32-20-15(19-17(9-27-20)29-23(36)30(19)2)7-16(22(32)35)21(34)28-8-13-3-5-14(25)6-4-13;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13/h5-9,11H,4,10,12-14H2,1-3H3,(H,30,36);3-7,9H,8,10-12H2,1-2H3,(H,28,34)(H,29,36);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33)
InChIKeyIJVFNBCLUQKADM-UHFFFAOYSA-N
XLogP6.13
TPSA355.67 Ų
H-Bond Donors6
H-Bond Acceptors22
Rotatable Bonds17
Heavy Atoms108
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001540.85
LogP ≤ 56.13
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1022

Analyze 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(4-chlorophenyl)methyl]-1-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
CID 71744871
5,6-diamino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-oxo-1,8-naphthyridine-3-carboxamide
CID 89863118
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-13-oxa-6,8,11,17-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-1,3,7,9,11-pentaene-4-carboxamide
CID 89863126
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-15-oxa-6,8,11,17-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-1,3,7,9,16-pentaene-4-carboxamide
CID 89863128
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,7-dioxo-1,3-dihydroimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
CID 89863130
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide
CID 89863139
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-3-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
CID 89863167
6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide
CID 89863176
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
CID 89863181
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-oxo-6,8,11,16-tetrazatetracyclo[8.6.0.02,7.011,15]hexadeca-1,3,7,9,15-pentaene-4-carboxamide
CID 89863189
N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2-(1-methylpyrrolidin-2-yl)-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
CID 89863192
N-[(4-chlorophenyl)methyl]-2-(dimethylamino)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-3-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
CID 89863195

Frequently Asked Questions

What is the IUPAC name of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The IUPAC name of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide (CID 158720267) is 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide.
What is the SMILES notation for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The canonical SMILES for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide is CCn1c(=O)n(C)c2c3cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n(CC(=O)N4CC(C)(F)C4)c3ncc21.CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.Cn1c(=O)[nH]c2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.
What is the InChIKey of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
The InChIKey is IJVFNBCLUQKADM-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26ClFN6O4.C24H22ClFN6O4.C23H24ClFN6O3/c1-4-33-19-11-29-22-17(21(19)31(3)25(33)38)9-18(23(36)30-10-15-5-7-16(27)8-6-15)24(37)34(22)12-20(35)32-13-26(2,28)14-32;1-24(26)11-31(12-24)18(33)10-32-20-15(19-17(9-27-20)29-23(36)30(19)2)7-16(22(32)35)21(34)28-8-13-3-5-14(25)6-4-13;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13/h5-9,11H,4,10,12-14H2,1-3H3,(H,30,36);3-7,9H,8,10-12H2,1-2H3,(H,28,34)(H,29,36);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33).
What are the key properties of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide?
6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide has a molecular weight of 1540.85 g/mol, XLogP of 6.13, 17 rotatable bonds, 6 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-3-ethyl-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-2,7-dioxo-3H-imidazo[4,5-c][1,8]naphthyridine-8-carboxamide is sourced from PubChem (CID 158720267), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).